iANTHUS CAPITAL HOLDINGS (ITHUF) Retained Earnings (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Retained Earnings came in at -$1.4 billion in Q1 2026, down 4.49% year-on-year from -$1.5 billion in Q1 2025, and down 1.04% quarter-over-quarter from -$1.4 billion in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Retained Earnings (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Retained Earnings across 7 years of filings, most recently posting -$1.4 billion for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$1.4 billion, down 4.49% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.4 billion (down 4.49% YoY), and the FY2025 annual result was -$1.4 billion, down 3.01% from the prior year.
- Retained Earnings came in at -$1.4 billion for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from -$1.4 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$811.7 million in Q1 2022 to a low of -$1.4 billion in Q1 2026.
- The 5-year median for Retained Earnings is -$1.3 billion (2024), against an average of -$1.3 billion.
- Across the five-year window, Retained Earnings slumped 56.41% in 2023 and grew 0.19% in 2025, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Retained Earnings stood at -$1.3 billion in 2022, then declined by 6.12% to -$1.3 billion in 2023, then slipped by 0.58% to -$1.3 billion in 2024, then fell by 3.01% to -$1.4 billion in 2025, then fell by 1.04% to -$1.4 billion in 2026.
- The last three Retained Earnings figures came in at -$1.4 billion (Q1 2026), -$1.4 billion (Q4 2025), and -$1.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | -1.39 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.39 Bn |
| Dec 31, 2025 | -1.38 Bn |
| Sep 30, 2025 | -1.36 Bn |
| Jun 30, 2025 | -1.35 Bn |
| Mar 31, 2025 | -1.33 Bn |
| Dec 31, 2024 | -1.34 Bn |
| Sep 30, 2024 | -1.36 Bn |
| Jun 30, 2024 | -1.35 Bn |
| Mar 31, 2024 | -1.33 Bn |
| Dec 31, 2023 | -1.33 Bn |
| Sep 30, 2023 | -1.31 Bn |
| Jun 30, 2023 | -1.29 Bn |
| Mar 31, 2023 | -1.27 Bn |
| Dec 31, 2022 | -1.25 Bn |
| Sep 30, 2022 | -1.21 Bn |
| Jun 30, 2022 | -1.19 Bn |
| Mar 31, 2022 | -811.70 Mn |
| Dec 31, 2021 | -801.63 Mn |
| Sep 30, 2021 | -774.69 Mn |
| Jun 30, 2021 | -758.85 Mn |